E
S. Wu et al.
Letter
Synlett
Eur. J. Org. Chem. 2013, 858. (e) Zeng, L. Y.; Yi, W. B.; Cai, C. Eur. J.
Org. Chem. 2012, 559. (f) Froehr, T.; Sindlinger, C. P.; Kloeckner,
U.; Finkbeiner, P.; Nachtsheim, B. J. Org. Lett. 2011, 13, 3754.
(g) Lamani, M.; Prabhu, K. R. J. Org. Chem. 2011, 76, 7938.
(h) Yuan, Y.; Ji, X.; Zhao, D. Eur. J. Org. Chem. 2010, 5274.
(i) Reddy, K. R.; Maheswari, C. U.; Venkateshwar, M.; Kantam, M.
L. Eur. J. Org. Chem. 2008, 3619. (j) Liotta, D. Acc. Chem. Res.
1984, 17, 28.
O
S
R2R3NH
R1SO2Na
R2
R3
m-CPBA
R1SO2Br
R1
N
(n-C4H9)4NBr
Br2
O
Scheme 3 Proposed mechanism for the preparation of sulfonamides
In summary, we have developed a now and convenient
procedure for the preparation of sulfonamides from sodium
sulfinates and amines in the presence of (n-C4H9)4NBr and
m-CPBA at room temperature in air. This one-pot reaction
has some advantages such as readily available starting ma-
terials, mild reaction conditions, simple procedure, and
good yields. Furthermore, the one-pot reaction via sulfonyl
bromides under neutral conditions will extend the applica-
tion scope of molecular iodine in organic synthesis.
(8) (a) Lin, Y.-M.; Lu, G.-P.; Cai, C.; Yi, W.-B. Org. Lett. 2015, 17,
3310. (b) Kariya, A.; Yamaguchi, T.; Nobuta, T.; Tada, N.; Miura,
T.; Itoh, A. RSC Adv. 2014, 4, 13191. (c) Katrun, P.; Hongthong, S.;
Hlekhlai, S.; Pohmakotr, M.; Reutrakul, V.; Soorukram, D.;
Jaipetch, T.; Kuhakarn, C. RSC Adv. 2014, 4, 18933. (d) Gao, W.-
C.; Zhao, J.-J.; Hu, F.; Chang, H.-H.; Li, X.; Wei, W.-L. RSC Adv.
2015, 5, 25222. (e) Katrun, P.; Mueangkaew, C.; Pohmakotr, M.;
Reutrakul, V.; Jaipetch, T.; Soorukram, D.; Kuhakarn, C. J. Org.
Chem. 2014, 79, 1778. (f) Xiao, F.-H.; Chen, H.; Xie, H.; Chen, S.-
Q.; Yang, L.; Deng, G.-J. Org. Lett. 2014, 16, 50. (g) Xiao, F.-H.; Xie,
H.; Liu, S.-W.; Deng, G.-J. Adv. Synth. Catal. 2014, 356, 364.
(9) (a) Yang, K.; Ke, M.; Lin, Y.-G.; Song, Q.-L. Green Chem. 2015, 17,
1395. (b) Pan, X.-J.; Gao, J.; Liu, J.; Lai, J.-Y.; Jiang, H.-F.; Yuan, G.-
Q. Green Chem. 2015, 17, 1400. (c) Wei, W.; Liu, C.-L.; Yang, D.-
S.; Wen, J.-W.; You, J.-M.; Wang, H. Adv. Synth. Catal. 2015, 357,
987. (d) Chonchanok, B.; Danupat, B.; Sirilata, Y. Eur. J. Org.
Chem. 2015, 1575. (e) Zhao, J.-W.; Xu, J.-X.; Chen, J.-X.; Wang,
X.-Q.; He, M.-H. RSC Adv. 2014, 4, 64698.
(10) A Typical Procedure for the Preparation of Sulfonamides
In mixed solvent THF–MeOH (30:1, 2.0 mL), sodium sulfinates 1
(0.45 mmol), amines 2 (0.30 mmol), (n-Bu)4NBr (0.36 mmol),
and m-CPBA (0.3 mmol) were added successively. The suspen-
sion mixture was vigorously stirred at r.t. for 12 h. Upon com-
pletion, the reaction was quenched by addition of sat. aq
Na2S2O3 (2 mL), sat. aq Na2CO3 (8 mL), and H2O (5 mL), respec-
tively. The mixture was extracted with CH2Cl2 (3 × 5 mL) and
the combined organic phase was dried over anhydrous Na2SO4,
filtered, and concentrated under reduced pressure. The residue
was then purified on a silica gel plate (PE–EtOAc = 3:1) to
furnish products 3.
References and Notes
(1) (a) Supuran, C. T.; Casini, A.; Scozzafava, A. Med. Res. Rev. 2003,
23, 535. (b) Winum, J. Y.; Scozzafava, A.; Montero, J. L.; Supuran,
C. T. Med. Res. Rev. 2006, 26, 767. (c) Kleemann, A.; Engel, J.;
Kutscher, B.; Reichert, D. Pharmaceutical Substances, Synthesis
Patents, Applications; Thieme: Stuttgart, 1999. (d) Reddy, N. S.;
Mallireddigari, M. R.; Cosenza, K. G.; Bell, S. C.; Reddy, E. P.;
Reddy, M. V. R. Bioorg. Med. Chem. Lett. 2004, 14, 4093.
(e) Stranix, B. R.; Lavallee, J. F.; Sevigny, G.; Yelle, J.; Perron, V.;
Leberre, N.; Herbart, D.; Wu, J. J. Bioorg. Med. Chem. Lett. 2006,
16, 3459. (f) Basanagouda, M.; Shivashankar, K.; Kulkarni, M. V.;
Rasal, V. P.; Patel, H.; Mutha, S. S.; Mohite, A. A. Eur. J. Med.
Chem. 2010, 45, 1151. (g) Chohan, Z. H.; Youssoufi, M. H.;
Jarrahpour, A.; Hadda, T. B. Eur. J. Med. Chem. 2010, 45, 1189.
(2) (a) Green, T. W.; Wuts, P. G. M. Protecting Groups in Organic Syn-
thesis; Wiley-Interscience: New York, 1999. (b) Chandrasekhar,
S.; Mohapatra, S. Tetrahedron Lett. 1998, 39, 695.
(3) (a) Andersen, K. In Comprehensive Organic Chemistry; Pergamon
Press: Oxford, 1979, Vol. 3. (b) Sridhar, R.; Srinivas, B.; Kumar, V.
P.; Narender, M.; Rao, K. R. Adv. Synth. Catal. 2007, 349, 1873.
(c) Harmata, M.; Zheng, P.; Huang, C.; Gomes, M. G.; Ying, W.;
Ranyanil, K.-O.; Balan, G.; Calkins, N. L. J. Org. Chem. 2007, 72,
683.
(4) (a) Yin, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 6043.
(b) Burton, G.; Cao, P.; Li, G.; Rivero, R. Org. Lett. 2003, 5, 4373.
(c) Rosen, B. R.; Ruble, J. C.; Beauchamp, T. J.; Navarro, A. Org.
Lett. 2011, 13, 2564. (d) Baffoe, J.; Hoe, M. Y.; Touré, B. B. Org.
Lett. 2010, 12, 1532. (e) Lam, P. Y. S.; Vincent, G.; Clark, C. G.;
Deudon, S.; Jadhav, P. K. Tetrahedron Lett. 2001, 42, 3415.
(f) Rao, S. K.; Wu, T.-S. Tetrahedron 2012, 68, 7735. (g) Zhu, M.;
Fujita, K.; Yamaguchi, R. Org. Lett. 2010, 12, 1336. (h) Watson, A.
J. A.; Maxwell, A. C.; Williams, J. M. J. J. Org. Chem. 2011, 76,
2328. (i) Kalita, B.; Lamar, A. A.; Nicholas, K. M. Chem. Commun.
2008, 4291. (j) Xiao, B.; Gong, T. J.; Xu, J.; Liu, Z. J.; Liu, L. J. Am.
Chem. Soc. 2011, 133, 1466.
N-Benzylbenzenesulfonamide (3a)
White solid; mp 82–83 °C (lit.12 85–87 °C). IR (KBr): 3329, 1326,
1162, 1093, 1061, 750, 687 cm–1. 1H NMR (500 MHz, CDCl3): δ =
7.86 (d, J = 7.2 Hz, 2 H), 7.59–7.54 (m, 1 H), 7.50–7.45 (m, J = 7.7
Hz, 2 H), 7.27–7.21 (m, 3 H), 7.20–7.16 (m, 2 H), 5.43 (t, J = 6.1
Hz, 1 H), 4.12 (d, J = 6.3 Hz, 2 H). 13C NMR (125 MHz, CDCl3): δ =
139.8, 136.2, 132.5, 129.0, 128.5, 127.7, 127.6, 126.9, 47.0. ESI-
MS: m/z (%) = 265 (100) [M + NH4]+.
N-(4-Methoxybenzyl)benzenesulfonamide (3b)
White solid; mp 71–72 °C (lit.13 72–75°C). IR (KBr): 3281, 1513,
1321, 1254, 1158, 1091, 1031, 858, 730, 685, 590 cm–1. 1H NMR
(500 MHz, CDCl3): δ = 7.85–7.81 (m, 2 H), 7.57–7.52 (m, 1 H),
7.47 (t, J = 7.7 Hz, 2 H), 7.08 (d, J = 8.6 Hz, 2 H), 6.75 (d, J = 8.7 Hz,
2 H), 5.38 (t, J = 6.1 Hz, 1 H), 4.04 (d, J = 6.1 Hz, 2 H), 3.73 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 159.0, 139.8, 132.4, 129.1, 128.9,
128.2, 126.9, 113.8, 55.1, 46.5. ESI-MS: m/z (%) = 295 (100) [M + NH4]+.
4-(Phenylsulfonyl)morpholine (3f)
(5) (a) Tang, X.; Huang, L.; Qi, C.; Wu, X.; Wu, W.; Jiang, H. Chem.
Commun. 2013, 49, 6102. (b) Moon, S.-Y.; Nam, J.; Rathwell, K.;
Kim, W.-S. Org. Lett. 2014, 16, 338. (c) Huang, X.; Wang, J.; Ni, Z.;
Wang, S.; Pan, Y. Chem. Commun. 2014, 4582.
White solid; mp 107–108 °C (lit.14 117–119 °C). IR (KBr): 2979,
2862, 1450, 1347, 1261, 1168, 1109, 943, 746, 693, 579, 532
1
cm–1. H NMR (500 MHz, CDCl3): δ = 7.78–7.73 (m, 2 H), 7.66–
(6) Finkbeiner, P.; Nachtsheim, B. J. Synthesis 2013, 45, 979.
(7) (a) Zhao, J.; Li, P.; Xia, C.; Li, F. Chem. Commun. 2014, 50, 4751.
(b) Guo, S.; Yu, J.-T.; Dai, Q.; Yang, H.; Cheng, J. Chem. Commun.
2014, 50, 6240. (c) Wu, X.-F.; Gong, J.-L.; Qi, X. Org. Biomol.
Chem. 2014, 12, 5807. (d) Jia, Z.; Nagano, T.; Li, X.; Chan, A. S. C.
7.60 (m, 1 H), 7.58–7.53 (m, 2 H), 3.73 (t, J = 4.8 Hz, 4 H), 3.00 (t,
J = 4.7 Hz, 4 H). 13C NMR (125 MHz, CDCl3): δ = 135.1, 133.0,
129.1, 127.8, 66.0, 45.9. ESI-MS: m/z (%) = 228 (100) [M + H]+.
N-(4-Chlorobenzyl)-4-methylbenzenesulfonamide (3k)
White solid; mp 92–93 °C (lit.15 88 °C). IR (KBr): 3234, 1641,
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–F